PreClinical Drug Test

A major focus of the USC-CHLA IPCR is to develop robust preclinical testing systems to evaluate new drugs and drug combinations for their potential to treat childhood cancer. IPCR investigators have developed novel technologies for assessing cytotoxicity in cell culture and are actively establishing and characterizing xenografts from a variety of childhood cancers in the Leukemia Preclinical Testing Lab.

 

PreClinical Drug Test

Core Laboratories